THE 2-MINUTE RULE FOR API IN PHARMACEUTICAL MANUFACTURING

“The existing problem has uncovered some structural weaknesses inside the EU’s medicines source chain along with a high dependence on non-EU nations for active pharmaceutical ingredients,” Kyriakides said. She recommended that supply chain challenges be dealt with in an EU pharmaceutical approach expected being introduced by the top from the